Phosphatidylinositol 4-kinase II beta negatively regulates invadopodia formation and suppresses an invasive cellular phenotype
MOLECULAR BIOLOGY OF THE CELL
Authors: Alli-Baloguna, Ganiyu Olabanji; Gewinner, Christina A.; Jacobs, Ruth; Kriston-Vizi, Janos; Waugh, Mark G.; Minogue, Shane
Abstract
The type II phosphatidylinositol 4-kinase (PI4KII) enzymes synthesize the lipid phosphatidylinositol 4-phosphate (PI(4)P), which has been detected at the Golgi complex and endosomal compartments and recruits clathrin adaptors. Despite common mechanistic similarities between the isoforms, the extent of their redundancy is unclear. We found that depletion of PI4KII alpha and PI4KII beta using small interfering RNA led to actin remodeling. Depletion of PI4KII beta also induced the formation of invadopodia containing membrane type I matrix metalloproteinase (MT1-MMP). Depletion of PI4KII isoforms also differentially affected trans-Golgi network (TGN) pools of PI(4)P and post-TGN traffic. PI4KII beta depletion caused increased MT1-MMP trafficking to invasive structures at the plasma membrane and was accompanied by reduced colocalization of MT1-MMP with membranes containing the endosomal markers Rab5 and Rab7 but increased localization with the exocytic Rab8. Depletion of PI4KII beta was sufficient to confer an aggressive invasive phenotype on minimally invasive HeLa and MCF-7 cell lines. Mining oncogenomic databases revealed that loss of the PI4K2B allele and under-expression of PI4KII beta mRNA are associated with human cancers. This finding supports the cell data and suggests that PI4KII beta may be a clinically significant suppressor of invasion. We propose that PI4KII beta synthesizes a pool of PI(4)P that maintains MT1-MMP traffic in the degradative pathway and suppresses the formation of invadopodia.
A case-control association study and family-based expression analysis of the bipolar disorder candidate gene PI4K2B
JOURNAL OF PSYCHIATRIC RESEARCH
Authors: Houlihan, Lorna M.; Christoforou, Andrea; Arbuckle, Margaret I.; Torrance, Helen S.; Anderson, Susan M.; Muir, Walter J.; Porteous, David J.; Blackwood, Douglas H.; Evans, Kathryn L.
Abstract
Bipolar disorder, schizophrenia and recurrent major depression are complex psychiatric illnesses with a substantial, yet unknown genetic component. Linkage of bipolar disorder and recurrent major depression with markers on chromosome 4p15-p16 has been identified in a large Scottish family and three smaller families. Analysis of haplotypes in the four chromosome 4p-linked families, identified two regions, each shared by three of the four families, which are also supported by a case-control association study. The candidate gene phosphatidylinositol 4-kinase type-if beta (PI4K2B) lies within one of these regions. PI4K2B is a strong functional candidate as it is a member of the phosphatidylinositol pathway, which is targeted by lithium for therapeutic effect in bipolar disorder. Two approaches were undertaken to test the PI4K2B candidate gene as a susceptibility factor for psychiatric illness. First, a case-control association study, using tagging SNPs from the PI4K2B genomic region, in bipolar disorder (n = 368), schizophrenia (n = 386) and controls (n = 458) showed association with a two-marker haplotype in schizophrenia but not bipolar disorder (rs10939038 and rs17408391, global P = 0.005, permuted global P = 0.039). Second, expression studies at the allele-specific mRNA and protein level using lymphoblastoid cell lines from members of the large Scottish family, which showed linkage to 4p15-p16 in bipolar disorder and recurrent major depression. showed no difference in expression differences between affected and non-affected family members. There is no evidence to suggest that PI4K2B is contributing to bipolar disorder in this family but a role for this gene in schizophrenia has not been excluded. (C) 2009 Elsevier Ltd. All rights reserved.